Background: LKB1 is a serine/threonine kinase that is essential in metabolism and tumor suppression. Results: LKB1 interacts with IKK␤ and suppresses NF-B activation in response to LPS. Conclusion: LKB1 inhibits LPS-induced inflammatory responses. Significance: This work reveals a novel mechanism for regulating LPS-induced inflammation.
LPS is a component of the outer membrane of Gram-negative bacteria and acts as a potent stimulator of innate immunity in diverse eukaryotic species (1) . LPS activates macrophages to produce various pro-inflammatory cytokines, such as TNF-␣, IL-6 (2) , and also other pro-inflammatory mediators such as inducible NO synthase (iNOS) 3 and COX2 (3, 4) . These mediators serve as important mechanisms in provoking efficient immune response and protecting the host from bacterial infection (5) . However, excessive production of pro-inflammatory mediators may lead to acute phase endotoxemia leading to tissue injury, organ failure, and even death (6) .
Activation of the transcription factor NF-B represents a pivotal element in signaling induced by LPS. The prototypical form of NF-B is a heterodimeric complex consisting of a DNA binding subunit and a transactivation subunit (7) . In unstimulated cells, the NF-B complex is retained in the cytoplasm by IB␣ and is inactive. LPS binding to Toll-like receptor 4 (TLR4) leads to activation of the IB kinase (IKK) complex that subsequently phosphorylates IB␣, targeting it for degradation. Released NF-B dimers then translocate to the nucleus where they bind to specific DNA sequences to promote transcription of target genes (8) . Given the broad spectrum of biological outcomes of NF-B signaling, its activation must be tightly regulated. Activation of NF-B is controlled by the IKK complex, which is composed of two catalytic subunits (IKK␣ and IKK␤) and one regulatory subunit IKK␥ (9) . Despite the high level of homology between IKK␣ and IKK␤, phosphorylation of IB proteins during canonical pathway activation is performed almost exclusively by IKK␤ (10) . IKK␤ is also required for the phosphorylation of RelA/p65 on serine 536, which enhances NF-B transcriptional activity (11) . Although IKK␤ plays an essential role in NF-B activation, the mechanisms involved in the regulation of IKK␤ remain poorly understood.
Liver kinase B1 (LKB1) is a serine-threonine kinase that was first identified as a tumor suppressor responsible for Peutz-Jeghers syndrome (12, 13) . Expression of LKB1 is ubiquitous in adult as well as in fetal tissues. Global Lkb1 knock-out is embryonically lethal in mice (14) . Various Lkb1 tissue-and cell-specific knock-out models have revealed that LKB1 impacts a wide range of processes, such as cardiac function, angiogenesis, adipogenesis, and glucose homeostasis (15) (16) (17) (18) (19) (20) . Recently, LKB1 was found to have prominent roles in hematopoietic stem cell survival and renewal (21) (22) (23) , suggesting an important function of LKB1 in hematopoietic cells. T cells lacking LKB1 displayed defects in maturation and viability, yet showed increased activation and inflammatory cytokine production upon T cell receptor stimulation (24, 25) . These studies suggest that LKB1 plays an important role in immunity. However, the role of LKB1 in macrophages, the major components of hematopoietic cells and the effector cells in the front line of innate immune responses, remains unclear. Here we report that LPS stimulation increases the phosphorylation of LKB1 at Ser-428, which enhances its binding to IKK␤, resulting in suppressed NF-B activation. We conclude that LKB1 functions as a negative regulator of LPS-induced NF-B activation and inflammation in macrophage.
EXPERIMENTAL PROCEDURES
Materials-Lipopolysaccharides (Escherichia coli 0111:B4) was from Sigma-Aldrich. ELISA kits for quantifying TNF-␣ and IL-6 were purchased from R&D Systems. Protein A-Sepharose CL-4B beads were from GE Healthcare. EMSA kit for NF-B binding affinity was from Panomics. p-NFB-Luc plasmid was from Stratagene.
Antibodies-Antibodies against phospho-LKB1 (Ser-428), phospho-IKK␣/␤ (Ser-177/181), IKK␤, phospho-p65 (Ser-536), p65, phospho-IB␣ (Ser-32), phospho-JNK, MCP-1, COX2, GFP, and HA were purchased from cell Signaling. Antibodies against LKB1 and actin were from Santa Cruz Biotechnology, phospho-TAK1 was from Millipore, and FLAG was from Sigma.
Animals-LKB1-floxed (LKB1 flox/flox ) mice and LysM-Cre mice were purchased from The Jackson Laboratory. To generate myeloid-specific LKB1 KO mice, LKB1 flox/flox mice were cross-bred with LysM-Cre mice. The animals were housed in a controlled environment (20 Ϯ 2°C, 12-h/12-h light/dark cycle), where they were maintained on a standard chow diet with free access to water. The animal protocol was reviewed and approved by the Animal Care and Use Committee at the University of Oklahoma Health Sciences Center.
Cell Culture-Raw264.7 macrophages were cultured in Dulbecco's modified Eagle's medium containing 10% heat-inactivated fetal bovine serum, 100 units/ml penicillin, 100 g/ml streptomycin, and 2 mM L-glutamine in a humidified atmosphere of 5% CO 2 at 37°C. Bone marrow was isolated from tibiae and femurs of mice and cultured in RPM1640 medium containing 10% fetal bovine serum supplemented with mouse recombinant macrophage colony-stimulating factor for 7 days.
Immunoprecipitation and Immunoblotting-Cells were lysed with ice-cold buffer from Santa Cruz Biotechnology containing 20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM Na 2 EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM glycerophosphate, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml leupeptin, 10 g/ml aprotinin, 1 mM Na 3 VO 4 , and 10 mM NaF. Lysates were centrifuged at 10,000 ϫ g for 10 min at 4°C. Protein concentration was measured using the BCA protein assay. Cleared lysates were incubated with the indicated antibodies overnight plus 1 additional h with protein A-Sepharose beads. The pellets were then washed five times with ice-cold lysis buffer and resuspended in SDS sample buffer. Eluted immunoprecipitates or whole cell lysates were separated by SDS-PAGE and analyzed by immunoblotting.
Electrophoretic Mobility Shift Assay-Standard EMSA was performed to detect NF-B activation in nuclear extracts from bone marrow-derived macrophages according to the manufacturer's instructions (Panomics, EMSA gel-shift kit). A commercially available biotinylated oligonucleotide encoding the NF-B motif 5Ј-AGTTGAGGGGACTTTCCCAGGC-3Ј was used as a canonical probe (Panomics, AY1030P).
Plasmid Construction and Transfection-LKB1 S428A mutant (FLAG-tagged) was generated using the QuikChange II site-directed mutagenesis kit (Stratagene) according to the manufacturer's instructions. The specific primers for sitedirected mutagenesis were as follows: forward, 5Ј-ATCCG-CCGGCTGGCGGCCTGCAAGCAGCAG-3Ј, and reverse, 5Ј-CTGCTGCTTGCAGGCCGCCAGCCGGCGGAT-3Ј. The mutation was verified by DNA sequencing. The Lipofectamine TM 2000 kit (from Invitrogen) and the Amaxa (Lonza, Germany) nucleofection system were used for transfection of 293T cells and Raw264.7 cells, respectively.
NF-B Luciferase Assay-Cells were transfected with B-Luc plus Renilla-Luc control. 24 h after transfection, cells were stimulated with or without LPS for 6 h. Luciferase activity was determined using a Dual-Glo luciferase assay system kit (Promega) and was normalized on the basis of Renilla luciferase activity. Results are presented as relative luciferase activity over the control group.
Statistical Analysis-Data are presented as the means Ϯ S.E. from at least three independent experiments. The statistical significance of differences between two groups was analyzed with Student's t test. Values of p Ͻ 0.05 were considered statistically significant.
RESULTS

LKB1 Inhibits LPS-induced Inflammatory Responses in
Macrophages-To investigate the role of macrophage LKB1 in innate immune responses, myeloid cell-specific LKB1 KO mice were generated by crossing LKB1 flox/flox mice with LysM-Cre mice (Fig. 1A) . The mice genotypes were confirmed by PCR ( Fig. 1B ). Western blot analysis (Fig. 1C ) confirmed the absence of LKB1 protein in bone marrow-derived macrophages (BMDMs) of LKB1 KO mice, whereas LKB1 protein in white adipose tissue, liver, and other tissues remained comparable with their littermate control mice (data not shown).
To examine the effects of LKB1 deletion on macrophage cytokine production, the BMDMs isolated from WT and LKB1 KO mice were stimulated with LPS or vehicle for 6 h. After the stimulation, cytokine production was monitored. Under basal conditions, the levels of pro-inflammatory cytokines TNF-␣ and IL-6 were low in both WT and LKB1 KO macrophages, and no difference was found between the two groups. However, LPS dramatically increased the production of TNF-␣ and IL-6 in BMDMs, and their levels were significantly higher in LKB1 KO macrophages as compared with WT macrophages (Fig. 1 , D and E). We further analyzed the expression of pro-inflammatory proteins such as iNOS, COX2, and MCP-1 in cell lysates. All these pro-inflammatory mediators were increased in LKB1 KO macrophages relative to WT controls upon LPS stimulation (Fig. 1F ). In line with these findings, nitrite concentrations in the culture supernatant of BMDMs were higher in LKB1 KO than in WT BMDMs after LPS stimulation ( Fig. 1G ). All these results suggested that LKB1 deletion caused higher levels of cytokine production and the induction of pro-inflammatory enzymes in macrophages.
LKB1 Inhibits LPS-induced NF-B Activation-As NF-B is the central regulator of inflammatory responses to LPS, we next examined whether or not LKB1 suppressed inflammation by inhibiting LPS-induced NF-B activation. As shown in Fig. 2 , A and B, LPS-induced phosphorylation and degradation of IB␣ were increased in LKB1 KO as compared with WT macrophages. In addition, phosphorylation of p65 at Ser-536, which is essential for NF-B transcriptional activity, was also significantly increased in LKB1 KO macrophages after LPS stimulation ( Fig. 2, C and D) . To confirm the role of LKB1 in NF-B activation, nuclear extracts of WT and LKB1 KO BMDMs were subjected to EMSA. EMSA analysis showed that LPS treatment induced the binding of NF-B to its consensus DNA, and this binding was significantly increased in LKB1 KO macrophages as compared with WT ( Fig. 2E) . To further investigate the transactivity of NF-B, BMDMs were transfected with NF-B luciferase reporter plasmid. As shown in Fig. 2F , there was no significant change of the luciferase activity between WT and LKB1 KO macrophages under basal conditions. In contrast, upon LPS stimulation, LKB1 KO macrophages showed a significant enhancement of NF-B luciferase activity as compared with WT control. Collectively, these experiments demon-strated that LKB1 inhibits LPS-induced NF-B activation in macrophages.
To further investigate the step at which LKB1 regulates NF-B activation, we examined the phosphorylation of transforming growth factor-␤ activated kinase-1 (TAK1), which is an essential upstream kinase involved in NF-B and JNK signaling pathways (26) . LKB1 deficiency did not affect phosphorylation of TAK1 and JNK (Fig. 2, G and H) , suggesting that LKB1 specifically inhibits LPS-induced NF-B signaling. We then investigated the phosphorylation of IKK, the master kinase for NF-B activation. As shown in Fig. 2 , I and J, LPS induced IKK phosphorylation in WT BMDMs, with a peak at 15 min after stimulation. LKB1 KO macrophages showed a similar pattern of IKK phosphorylation in response to LPS, but the extent of phosphorylation was significantly enhanced. These results suggested that LKB1 may specifically affect LPS-induced IKK phosphorylation.
LKB1 Interacts with IKK␤ in Response to LPS Stimulation-Given that LKB1 selectively regulated LPS-induced NF-B signaling (Fig. 2) , we speculated that physical interaction between LKB1 and core components of NF-B signaling might exist. Because IKK␤ plays a critical role in mediating NF-B activa- tion in response to pro-inflammatory cytokines and microbial products (27) , we hypothesized that LKB1 may physically interact with IKK␤. To this end, we performed immunoprecipitation assays with extracts from HEK293T cells that were cotransfected with HA-tagged IKK␤ and GFP-tagged LKB1 expression vectors. The results revealed the presence of IKK␤ in LKB1 immunoprecipitates (Fig. 3A) , and LKB1 in IKK␤ immunoprecipitates (Fig. 3B ). The endogenous association was further confirmed in Raw264.7 macrophages (Fig. 3C) , and more importantly in primary BMDMs (Fig. 3D ). Because LKB1 specifically regulates NF-B signaling upon LPS stimulation, but with little effect under basal conditions, we further investigated the association of LKB1 with IKK␤ under basal and LPSstimulated conditions. As shown in Fig. 3E , a weak association of LKB1 with IKK␤ was detected in unstimulated macrophages; this interaction was significantly increased after LPS stimulation. These data suggested that LKB1 interacts with IKK␤ in response to LPS stimulation.
Phosphorylation of LKB1 at Serine 428 Is Required for Interaction with IKK␤ and Suppression of LPS-induced NF-B
Signaling-To further explore the molecular mechanism by which LKB1 interacts with IKK␤ and suppresses NF-B activa- tion, we examined the responses of LKB1 to LPS stimulation. As shown in Fig. 4A , LPS significantly increased LKB1 phosphorylation at Ser-428, whereas it had no effect on phosphorylation at Ser-307 (Fig. 4A ). Levels of Ser-428 phosphorylation were in parallel to the enhanced interaction of LKB1 with IKK␤ ( Fig.  4B ), suggesting a role for LKB1 phosphorylation at Ser-428 in mediating LKB1 binding to IKK␤. To test this hypothesis, we mutated this serine residue to alanine and compared the ability of wild type LKB1 and S428A mutant to interact with IKK␤. As shown in Fig. 4C , LKB1 S428A mutation had no effect on LKB1 binding to IKK␤ under basal conditions, whereas this mutation abrogated LPS-enhanced interaction between LKB1 and IKK␤. However, LKB1 S307A mutation does not affect LKB1 interaction with IKK␤.
To further evaluate the effect of LKB1 S428A mutation on NF-B activation, we performed the NF-B luciferase reporter assay. As shown in Fig. 4D , there was no difference in NF-B activation among LacZ-, WT-, and S428A-transfected macrophages under basal conditions. However, WT LKB1 suppressed LPS-induced NF-B activation as compared with LacZ control, and this suppression was abolished by LKB1 S428A mutation. In addition, LPS-induced expression of MCP-1 and COX2, the pro-inflammatory mediators downstream of NF-B signaling, was also down-regulated by WT LKB1 but not the LKB1 S428A mutant. Taken together, these results suggest that phosphor-ylation of LKB1 at serine 428 is required for interaction with IKK␤ and suppression of NF-B signaling.
LKB1 Inhibits LPS-induced Inflammation in Vivo-Based on the above findings that LKB1 inhibits LPS-induced inflammatory responses in macrophages in vitro, we next investigated whether a similar scenario exists in vivo. We first examined LKB1 phosphorylation in mice challenged with PBS or LPS. As shown in Fig. 5A , LPS significantly increased LKB1 phosphorylation at Ser-428 in lung and liver tissues. We then detected NF-B signaling activation in myeloid-specific LKB1 KO mice and WT littermates challenged with PBS or LPS. As indicated in Fig. 5B , phosphorylation of IKK␣/␤ and IB␣ was significantly increased in LKB1 KO mice as compared with WT control after LPS challenge, suggesting an enhanced LPS-triggered NF-B activation in LKB1 KO mice. We further measured the abundance of pro-inflammatory cytokines in the serum. As shown in Fig. 5 , C and D, serum concentrations of TNF␣ and IL-6 were almost undetectable in the two genotypes in PBS control group. However, these pro-inflammatory cytokines were drastically induced by LPS challenge and were significantly higher in LKB1 KO versus WT littermates (Fig. 5, C and D) .
Excessive production of pro-inflammatory cytokines has been implicated in the pathogenesis of tissue injury (28, 29) . In sepsis patients, pathologic alterations of the lung are most frequently observed (30) . Therefore, lung tissues were next sub- jected to histopathological analysis. In the PBS-treated group, no morphologic alterations were observed in the lungs from LKB1 KO mice as compared with those of WT animals. However, after 20 h of LPS challenge, the lung injury in LKB1 KO mice was much more severe than that of WT mice, as indicated by more cellular infiltration and increased thickness of alveolar septa visualized by H&E staining (Fig. 5, E and F) . Consistently, pro-inflammatory mediators such as iNOS and COX2 were also significantly increased in LKB1 KO mice lung tissue as compared with those in WT mice (Fig. 5E ). These data indicated that macrophage LKB1 plays an essential role in protecting mice against LPS-induced inflammation in vivo.
DISCUSSION
In the present study, we have identified LKB1 as a negative regulator of LPS-induced NF-B activation and inflammatory responses in macrophages. We further demonstrated that LPS stimulation increases the phosphorylation of LKB1 at Ser-428, which enhances its binding to IKK␤ and suppresses NF-B activation.
NF-B plays an important role in immune and inflammatory responses, and its dysregulation has been associated with a number of inflammation-related diseases or disorders, including sepsis and septic shock (31), cardiovascular disease, asthma, atherosclerosis, diabetes, obesity, and cancer (32) (33) (34) . How-ever, the mechanisms that limit the duration and magnitude of NF-B signaling are poorly understood (35) . In this study, we have determined that LKB1 inhibits NF-B activation through LPS-induced LKB1 phosphorylation at Ser-428, resulting in increased binding of LKB1 with IKK. These results indicate that LKB1 may function as one of the physiological counter-regulatory elements that have evolved to ensure precise balance of immune responses.
The present study, coupled with evidence from previous studies, suggests that LKB1 phosphorylation is a potent antiinflammatory mechanism. ETC-1002, an investigational drug currently in Phase 2 development for treatment of dyslipidemia and other cardiometabolic risk factors, has been reported to enhance LKB1 phosphorylation and exerts its anti-inflammatory effects via an LKB1-dependent mechanism (36) . Globular adiponectin was reported to induce LKB1 phosphorylation and suppress ethanol-induced NF-B pathway (37) . Our laboratory has also previously demonstrated that metformin, which inhibits multiple inflammatory responses (38 -42) , can increase LKB1 phosphorylation at Ser-428 (43) . However, LKB1 phosphorylation was found to be required for thromboxane receptor-dependent NF-B activation and inflammatory responses in endothelial cells (44) . This contradictory finding suggests a complicated role for LKB1 in different cell types upon subjection to different stimuli. Whole cell lysates were loaded as control. C, Raw264.7 cells were transfected with FLAG-WT, FLAG-S428A, or Myc-WT, Myc-S307A plasmids. 24 h after transfection, cells were treated with or without LPS for 30 min and then lysed for immunoprecipitation. D, Raw264.7 cells were transfected with the indicated plasmids along with p-NFB-Luc and pTK-Renilla luciferase plasmids. 24 h after transfection, cells were stimulated with LPS or not for 6 h. Luciferase reporter activity was measured and normalized according to the manufacturer's instructions. Results are presented as relative luciferase activity over the control group. E, Raw264.7 cells were transfected with the indicated plasmids, and 24 h after transfection, cells were treated with or without LPS for 12 h. F, quantification of data as in E. *, p Ͻ 0.05 versus LacZ control treated with LPS. NS, not significant.
Our data demonstrated that LKB1 phosphorylation at Ser-428 enhances physical interaction of LKB1 with IKK␤, resulting in suppression of NF-B signaling. However, the exact mechanisms of how LKB1 phosphorylation affects this process remain unclear. Previous studies from our research group demonstrated that phosphorylation of LKB1 at Ser-428 can increase its nuclear export and activity (43, 45) . Therefore, it is possible that LPS-induced LKB1 phosphorylation increases its nucleus export, which would enable LKB1 to interact with IKK␤. As a serine/threonine kinase, it is also possible for LKB1 to serve as an upstream kinase of IKK␤, with a resulting phosphorylation of IKK␤, which may affect its activity and consequently affect NF-B activation. Further investigation is warranted.
In summary, our data have established LKB1 as a novel negative regulator of NF-B activation in macrophages, presenting LKB1 as a possible important target for treating endotoxic shock and other inflammatory diseases. 
